Melanoma

Showing NaN - NaN of 74

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Colorectal Carcinoma, Endometrial Carcinoma, Melanoma Trial in United States (Tegavivint)

Recruiting
  • Colorectal Carcinoma
  • +21 more
  • Dual X-ray Absorptiometry
  • +2 more
  • Birmingham, Alabama
  • +18 more
Jan 30, 2023

Melanoma Trial in Worldwide (Pembrolizumab, Vibostolimab, Pembrolizumab/Quavonlimab)

Recruiting
  • Melanoma
  • Pembrolizumab
  • +5 more
  • Los Angeles, California
  • +39 more
Jan 25, 2023

Melanoma Trial in Worldwide (Pembrolizumab, Vibostolimab, V937)

Recruiting
  • Melanoma
  • Pembrolizumab
  • +5 more
  • Los Angeles, California
  • +28 more
Jan 25, 2023

Melanoma Trial in Worldwide (Pembrolizumab, Quavonlimab, Vibostolimab)

Recruiting
  • Melanoma
  • Pembrolizumab
  • +4 more
  • Los Angeles, California
  • +34 more
Jan 25, 2023

Melanoma, NSCLC Trial in United States (brentuximab vedotin, pembrolizumab)

Recruiting
  • Melanoma
  • +2 more
  • Tucson, Arizona
  • +31 more
Jan 20, 2023

Locally Advanced or Metastatic Solid Tumors, NSCLC, HNSCC Trial in Australia, United States (RO7502175, Atezolizumab)

Recruiting
  • Locally Advanced or Metastatic Solid Tumors
  • +10 more
  • Aurora, Colorado
  • +6 more
Jan 4, 2023

Melanoma, Lymphoma, Solid Tumor Trial in Worldwide (Pembrolizumab)

Recruiting
  • Melanoma
  • +4 more
  • Pembrolizumab
  • Aurora, Colorado
  • +18 more
Jan 5, 2023

Ovarian Cancer, Cervical Cancer, Endometrial Cancer Trial in Worldwide (Enapotamab vedotin (HuMax-AXL-ADC))

Completed
  • Ovarian Cancer
  • +7 more
  • Enapotamab vedotin (HuMax-AXL-ADC)
  • Phoenix, Arizona
  • +40 more
Dec 12, 2022

Melanoma, NSCLC, Bladder Cancer Trial in Worldwide (Autogene cevumeran, Atezolizumab)

Active, not recruiting
  • Melanoma
  • +7 more
  • Scottsdale, Arizona
  • +36 more
Dec 22, 2022

Melanoma Trial in Worldwide (Dabrafenib, Trametinib, Placebos)

Active, not recruiting
  • Melanoma
  • Birmingham, Alabama
  • +209 more
Nov 14, 2022

Melanoma Trial in Worldwide (Nivolumab, Nivolumab + Relatlimab Fixed Dose Combination)

Recruiting
  • Melanoma
  • Nivolumab
  • Nivolumab + Relatlimab Fixed Dose Combination
  • Birmingham, Alabama
  • +185 more
Dec 3, 2022

Pancreatic Cancer, Small Bowel Cancer, Colorectal Cancer Trial in United States (Ulixertinib (BVD-523))

Available
  • Pancreatic Cancer
  • +20 more
  • Ulixertinib (BVD-523)
  • Birmingham, Alabama
  • +25 more
Nov 4, 2022

Melanoma Trial in Worldwide (Pembrolizumab, Placebo)

Active, not recruiting
  • Melanoma
  • Pembrolizumab
  • Placebo
  • Tucson, Arizona
  • +158 more
Oct 31, 2022

Improving Adolescent and Young Adult Self-Reported Data in

Recruiting
  • Breast Cancer, NOS
  • +11 more
  • Questionnaires
  • Fairbanks, Alaska
  • +313 more
Sep 20, 2022

Melanoma Trial in Aurora (VESANOID, Ipilimumab)

Active, not recruiting
  • Melanoma
  • Aurora, Colorado
    University of Colorado Hospital
Sep 7, 2022

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Melanoma Trial in Worldwide (Belvarafenib, Cobimetinib, Atezolizumab)

Recruiting
  • Melanoma
  • Orange, California
  • +23 more
Aug 24, 2022

Melanoma Trial in Australia, United States (mRNA-4157, Pembrolizumab)

Active, not recruiting
  • Melanoma
  • mRNA-4157
  • Pembrolizumab
  • Tucson, Arizona
  • +21 more
Aug 23, 2022

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Melanoma Trial in Worldwide (Pembrolizumab, Pembrolizumab/Quavonlimab, Lenvatinib)

Recruiting
  • Melanoma
  • Pembrolizumab
  • +2 more
  • Los Angeles, California
  • +28 more
Aug 12, 2022

Melanoma Trial in United States (CMP-001, Pembrolizumab)

Active, not recruiting
  • Melanoma
  • Phoenix, Arizona
  • +12 more
Aug 1, 2022

Melanoma, Solid Tumor Trial in Korea, Republic of, Spain, United States (DAY101, Pimasertib Hydrochloride)

Recruiting
  • Melanoma
  • Solid Tumor
  • Los Angeles, California
  • +13 more
Jul 27, 2022

Melanoma Trial in Worldwide (Encorafenib, Binimetinib, Pembrolizumab)

Recruiting
  • Melanoma
  • Tucson, Arizona
  • +112 more
Jul 26, 2022